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ABSTRACT
Objectives: Imiquimod (IQ) is used clinically for the topical treatment of external genital warts. IQ
is an immune response modifier and induces the expression of interferon- and other cytokines in
human Peripheral Blood Monocytes (PBMC). Trophoblasts have been previously shown to ex-
press inflammatory cytokines upon lipopolysaccharide (LPS) stimulation. The objective of this
study was to evaluate the ability of IQ to induce transcription of cytokines in trophoblasts.
Methods:A transformed human first trimester trophoblast cell line, HTR-8/SVneo, was cultured
in DMEM containing IQ at concentrations of 0 to 5.0 pg/ml. 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) viability assays were conducted to control for any drug-
induced cell death. Total RNA was isolated from trophoblasts at 0, 8 and 24 hours of culture and
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was conducted using specific am-
plimers for the inflammatory cytokines interleukin (IL)-I, IL-113, IL-6 and IL-8. RT-PCR of
[3-actin was performed to control for equal RNA loading.
Results: RT-PCR was unable detect an increase in either IL-I, IL-I, IL-6 or IL-8 mRNA in
first trimester trophoblasts cultured in the presence of 0 to 5.0 pg/mL of IQ for up to 24 hours.
RT-PCR confirmed equal RNA loading and MTT viability assays did not show loss of cell viability
at concentrations of IQ up to 5.0 pg/ml.
Conclusions: IQ, at the concentrations tested, did not induce the transcriptional expression of
inflammatory cytokines in human first trimester trophoblasts. These data suggest that IQ would not
induce the expression of inflammatory cytokines in placental trophoblasts. Infect. Dis. Obstet.
Gynecol. 8:105-111, 2000. (C) 2000 Wiley-Liss, Inc.
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miquimod (IQ), [l(2-methylpropyl)-lh-imidazo
[4,5-c]quinolin-4-amine], belongs to a class of im-
idazoquinolines with immunomodulatory charac-
teristics. IQ is commonly used in the treatment of
genital warts. This heterocyclic amine, which has
potent antiviral and antitumor activity, stimulates
the in vitro production of interferon-or (IFN-ot), in-
terleukin-lot (IL-lot), interleukin-l[3 (IL-113), in-
terleukin-6 (IL-6) and interleukin-8 (IL-8). 1-3
Mononuclear phagocytes have been shown to be
the cell type that is largely responsible for the ex-
pression of these cytokines following treatment
with IQ.z-3 The induction of these cytokines is
through transcriptional activation of cytokine-
specific mRNA’s. Placental trophoblasts share
many phenotypic similarities with monocytes and
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may therefore be affected by the immunomodula-
tory characteristics of IQ.
The human placenta is a multifunctional endo-
crine organ that serves as both a mechanical and
immunological barrier against the vertical transmis-
sion of infectious agents. Placental trophoblasts are
critical components of this barrier and have been
shown to express a variety of both proinflammatory
and immunoregulatory cytokines including IL-lot,
IL-l[3, IL-6 and IL-8, when stimulated.4 These
cytokines presumably function to elicit and modu-
late inflammatory immune responses, promote tro-
phoblast differentiation and aid in maintaining nor-
mal placental function,s Use of this drug during
pregnancy could potentially alter the normal cyto-
kine milieu at the maternal-fetal interface and
therefore adversely affect trophoblast and hence
placental function. This study was conducted to
determine if IQ is capable of altering the transcrip-
tional expression of immunomodulatory cytokines
in human first trimester trophoblasts in vitro.
SUBJECTS AND METHODS
Cell Culture
HTR-8/SVneo cells,6 derived from human first tri-
mester extravillous trophoblasts, possess a normal
trophoblast morphology and express cytokeratin,
human chorionic gonadotrophin and type IV colla-
genase. Cells were grown to confluency in Dulbec-
co’s Modified Eagle’s Medium (DMEM) (SIGMA,
St. Louis, MO), supplemented with 10% non-heat
inactivated fetal bovine serum, 1% L-glutamine, 50
U/mL penicillin and 5 lag/mL streptomycin
(GIBCO BRL, Gaithersburg, MD). Cells were cul-
tured at 37C in an atmosphere of 5% COz in 75
cmz flasks (VWR Scientific Products, Chicago, IL).
Experimental Culture Conditions and
RNA Isolation
Confluent HTR-8/SVneo monolayers were washed
three times in 4 mL of DMEM prior to culture
under experimental conditions. Cells were subse-
quently cultured in media alone or in the presence
of various concentrations (0 to 5.0 lag/mL) of IQ for
0, 8 or 24 hours. At each time point, total RNA was
isolated from cells using the TRIzol (R) Reagent
(GIBCO BRL, Gaithersburg, MD), in accordance
with the manufacturers’ instructions. RNA integ-
rity was assessed by agarose gel clectrophoresis and
quantitated spectrophotometrically at 260/280 nm.
Contaminating genomic DNA was digested with 4
U/sample of RQ1 DNase in x DNase buffer (Pro-
mega, Madison, WI), for 1.5 hr at room tempera-
ture. This trophoblast cell line has been shown pre-
viously to express various inflammatory cytokines
following lipopolysaccharide induction.4
Cell Viability Assay
Cell viability in media alone or in the presence of
IQ (0 to 5.0 pg/mL), was examined following 0, 8
and 24 hours of culture. A rapid colorimctric assay
utilizing the tetrazolium salt of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) (SIGMA), was conducted as described
previously. 7 Assays were performed in triplicate us-
ing a 96-well microtitre plate format and absor-
bances were determined using a plate-reading
spectrophotometer (Ceres UV900HDI, Bio-TEK
Instruments Inc., Winooski, VT) at a reference
wavelength of 630 nm and a test wavelength of 570
rim.
Reverse Transcription-Polymerase
Chain Reaction
RT-PCR amplification was conducted using am-
plimers to IL-la, IL-113, IL-6, IL-8 and 13-actin
(IDT Technologies, Coralville, IA). Sequence data
for the construction of amplimers was obtained
from the public domain. Total RNA (1 lag) was
reverse transcribed and the cDNA amplified in a 50
laL reaction volume containing x buffer (Perkin
Elmer Applied Biosystems, Norfolk, CT), 0.5 mM
sense and anti-sense primers, 2.0 mM Mn(OAc)e,
0.15 mM dNTPs, and 5 U/reaction of rTth enzyme
(Perkin Elmer Applied Biosystems, Norfolk, CT).
The PCR reaction was overlaid with 50 laL of ster-
ile mineral oil and reverse transcription occurred
for 60 min at 60C followed by a denaturation step
at 95C for 2 min. PCR amplification was per-
formed at a denaturation temperature of 95C for
45 sec and an annealing temperature of either 52C
(IL-113) or 55C (IL-lot, IL-6, II_,-8 and [3-actin), for
45 sec and 35 cycles. This was followed by a ter-
minal extension cycle at 72C for 15 rain. Reverse
transcription and PCR amplification were con-
ducted in a Perkin Elmer 480 DNA thermocycler
(Perkin Elmer Applied Biosystems). PCR products
were resolved by agarose gel clectrophoresis and
product sizes were estimated by comparison with a
molecular size standard (Pvu II digest of bacte-
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riophage DNA). [3-actin amplimers and where pos-
sible, cytokine amplimers, were designed to span
intronic regions in order to control for the presence
of contaminating genomic DNA. Levels of cyto-
kine and 13-actin mRNA were titrated by serial di-
lution prior to reverse transcription, in order to re-
main within the linear range of the PCR amplifi-
cations (data not shown). All reaction sets included
negative PCR and negative RNA controls.
RESULTS
HTR-8SVneo cell viability was examined follow-
ing 0, 8 and 24h of culture in the presence of IQ.
No concentration-dependent or time-dependent
change in cell viability was detected during the
course of this study (Fig. 1). Total RNA was iso-
lated from HTR-8SVneo cells grown under experi-
mental and control conditions for RT-PCR. RNA
integrity was confirmed by agarose gel electropho-
resis (Fig. 2). RT-PCR amplification of [3-actin was
conducted to ensure equal RNA loading through-
out the experiment. RT-PCR analysis demon-
strated the appearance of a single 309bp [3-actin
product of essentially equal intensity among all ex-
perimental and control sets (Fig. 3). RT-PCR
analysis was subsequently conducted to determine
the relative mRNA levels of specific immuno-
modulatory and proinflammatory cytokines. RT-
PCR amplification using amplimers to IL-lot (Fig.
4), IL-l[3 (Fig. 5), IL-6 (Fig. 6) and IL-8 (Fig. 7),
yielded discrete products of 500bp, 398bp, 494bp
and 217bp, respectively. No concentration-
dependent or time-dependent effect of IQ on cy-
tokine mRNA levels in human trophoblasts was
noted.
DISCUSSION
IQ is safe and effective for the topical treatment of
genital warts,s-9 The anti-viral nature of this drug is
attributed largely to the induced expression of
IFN-ot and other immunomodulatory cytokines by
monocytes. Trophoblasts, which are phenotypi-
cally similar to monocytes, are known to express
immunomodulatory and proinflammatory cyto-
kines following induction by infection stimuli.4
This study examined the ability of IQ to induce
the in vitro expression of similar cytokines in first
trimester trophoblasts. Such induction may be con-
traindicated during pregnancy because exposure to
an altered cytokine milieu could adversely affect
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Fig. I. HTR-8SVneo cell viability assay. Viability of first
trimester trophoblasts was evaluated following culture in
the presence of IQ (0, 0.05, 0.1, 0.5, 1.0 or 5.0 Ig/ml-) for
Oh (top), 8h (middle) and 24h (bottom).
trophoblast function or fetal immune develop-
ment. lo-ll
RT-PCR demonstrated neither a concentration-
dependent nor time-dependent induction of IL-
ot, IL-l[3, IL-6 or IL-8 in first trimester tropho-
blasts by IQ. The presence of RNA transcripts to
these cytokines in trophoblasts cultured under con-
trol conditions is consistent with previous observa-
tions suggesting that these cytokines may be ex-
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Fig. 2. Determination of RNA integrity. Total RNA was isolated from first trimester trophoblasts cultured in the presence
of IQ (0, 0.05, 0.1, 0.5, 1.0 and 5.0 Ig/mL) for Oh (lanes I-6), 8h (lanes 7-12) and 24h (lanes 13-18).
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Fig. 3. Transcriptional expression of [3-actin in trophoblasts. Human 13-actin was amplified from trophoblasts to control for
equal loading of RNA. RT-PCR amplification yielded a single 309bp product of nearly equal intensity from trophoblasts cultured
in the presence of IQ (0, 0. I, 0.5, 1.0 and 5.0 lug/mL) for Oh (lanes I-6), 8h (lanes 7-12) and 24h (lanes 13-18).
pressed at a low constitutive level.4 These results
are also consistent with previous observations sug-
gesting that IQ is largely immunomodulatory for
antigen presenting cells such as monocytes and
macrophages. Resident macrophages and mono-
cytes present within the placenta may therefore
respond to IQ treatment by expression of cyto-
kines. These data support the hypothesis that IQ
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Fig. 4. Transcriptional expression of IL-Ic in trophoblasts. RT-PCR yielded a single 500bp product of nearly equal intensity
from trophoblasts cultured in the presence of IQ (0, 0.05, 0. I, 0.5, 1.0 and 5.0 Ig/mL) for Oh (lanes I-6), 8h (lanes 7-12) and
24h (lanes 13-18).
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Fig. 5. Transcriptional expression of IL-113 in trophoblasts. RT-PCR yielded a single 398bp product of nearly equal intensity
from trophoblasts cultured in the presence of IQ (0, 0.05, 0. I, 0.5, 1.0 and 5.0 lg/mL) for Oh (lanes I-6), 8h (lanes 7-12) and
24h (lanes 13-18).
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Fig. 6. Transcriptional expression of IL-6 in trophoblasts. RT-PCR yielded a major 494bp product from trophoblasts cultured
in the presence of IQ (0, 0.05, 0.1, 0.5, 1.0 and 5.0 lug/mL) for Oh (lanes I-6), 8h (lanes 7-12) and 24h (lanes 13-18).
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Fig. 7. Transcriptional expression of IL-8 in trophoblasts. RT-PCR yielded a single 217bp product of nearly equal intensity
from trophoblasts cultured in the presence of IQ (0, 0.05, 0. I, 0.5, 1.0 and 5.0 iag/mL) for Oh (lanes I-6), 8h (lanes 7-12) and
24h (lanes 13-18).
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does not transcriptionally induce specific proin-
flammator and immunomodulatory cytokines in
placental trophoblasts.
CONCLUSIONS
Imiquimod does not induce the in vitro transcrip-
tion of the immunomodulatory cytokines IL-lot,
IL-113, IL-6 or IL-8 in human first trimester tro-
phoblasts. Imiquimod is therefore unlikely to alter
expression of these cytokines in the placenta. The
inability of imiquimod to transcriptiorally induce
cytokines in trophoblasts at the concentrations
tested resolves some of the concerns associated
with administering imiquimod during pregnancy.
Imiquimod, at the levels tested, does not contrain-
dicate use during pregnancy in humans. Further
evaluation in vivo will be necessary to confirm the
safety and efficacy of imiquimod during pregnancy.
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